Claim(permalink)
Der japanische Pharmakonzern Kowa habe in einer klinischen Phase-3-Studie die antivirale Wirksamkeit von Ivermectin zur Behandlung von Covid-19 bestätigt.
✓correctiv rating: not credible; published on 2022-02-16
Factors
veracity
not credible
Political Leaning
left political leaning
Sentiment
neutral sentiment
Date published
2022-02-16
Entities
MarsThe SilmarillionEuropean Medicines AgencyReutersNunTokyoWariniIvermectinOderFood and Drug AdministrationJapanAustraliaUruguayan Football AssociationMassachusetts Institute of TechnologyUnited StatesBau DistrictPharmaceuticals and Medical Devices AgencyUniversity of Cape TownRenato Steffen